Anti-(human Interleukin 33) (human Monoclonal Regn3500 .gamma.4-chain)
Anti-(human Interleukin 33) (human Monoclonal Regn3500 .gamma.4-chain) Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-(human Interleukin 33) (human Monoclonal Regn3500 .gamma.4-chain) is under investigation in clinical trial NCT03546907 (Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-il-33 Mab) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)).
Trade Name | Anti-(human Interleukin 33) (human Monoclonal Regn3500 .gamma.4-chain) |
Generic | Itepekimab |
Itepekimab Other Names | Immunoglobulin igg4 (230-proline), anti-(human interleukin 33) (human monoclonal regn3500 .gamma.4-chain), disulfide with human monoclonal regn3500 .kappa.-chain, dimer, Itepekimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-(human Interleukin 33) (human Monoclonal Regn3500 .gamma.4-chain)